Medication-induced parkinsonism
Parkinsonian tremor, muscular rigidity, or akinesia developing in association with medication use (most commonly neuroleptic/antipsychotic or dopamine-depleting agent)
Parkinsonian tremor, muscular rigidity, or akinesia developing in association with medication use (most commonly neuroleptic/antipsychotic or dopamine-depleting agent)
Persistent difficulty with speech sound production that interferes with speech intelligibility or prevents verbal communication of messages
Criteria met for major or mild NCD (substantial or modest cognitive decline in ≥1 domain)
Persistent or recurrent pattern of sleep disruption primarily due to alteration of the circadian system or misalignment between endogenous circadian rhythm and sleep-wake schedule
Acquisition and execution of coordinated motor skills is substantially below expected for chronological age and opportunity for skill learning
Inability to recall important autobiographical information (usually traumatic/stressful) inconsistent with ordinary forgetting; may include dissociative fugue (purposeful travel or bewildered wandering)
Abnormal and prolonged contraction of muscles of eyes, face, neck, limbs, or trunk developing in association with medication use
Criteria met for major or mild NCD
Persistent personality disturbance representing a change from the individual's previous characteristic personality pattern